Investors & Media Event Details Investor Relations Overview Corporate Governance Press Releases & Statements Events & Presentations SEC Filings Annuals and Proxies Investor FAQs Financials & Filings Stock Information Analyst Coverage Email Alerts Subscription Notice of Pendency of Settlement of Action Sage Therapeutics Conference Call to Discuss Results from Phase 2 of SAGE-217 in Major Depressive Disorder Dec 7, 2017 8:00 AM EST Listen to webcast
Sage Therapeutics Conference Call to Discuss Results from Phase 2 of SAGE-217 in Major Depressive Disorder Dec 7, 2017 8:00 AM EST Listen to webcast